Remicade (infliximab) - J&J
Cimzia (certolizumab pegol) - Astellas, UCB
Humira (adalimumab) - AbbVie
Tremfya (guselkumab) - J&J
Omvoh (mirikizumab-mrkz) - Eli Lilly
tofacitinib - Generic mfg.
Stelara (ustekinumab) - J&J
Skyrizi (risankizumab-rzaa) - AbbVie, Boehringer Ingelheim
Simponi (golimumab) - J&J
Rinvoq (upadacitinib) - AbbVie
Entyvio (vedolizumab) - Takeda
Zeposia (ozanimod) - BMS
Velsipity (etrasimod) - Pfizer
https://acg2026.eventscribe.net/ajaxcalls/PosterInfo.asp?efp=R01PT1FGR0UyNjkyNQ&PosterID=829826&rnd=0.6863442
 
Katharine Tippins MD 1; Adam Faye MD 2; Erica J. Brenner MD MSCR 3; Mary S. Hayney PharmD MPH BCPS 4; Francis A.. Farraye MD MSc MACG 5; Monika Fischer MD MS 6; Siddharth Singh MD MS 7; Huiping Xu PhD 8; Freddy Caldera DO PhD MS 9
 
Aug 29, 2026
 
Prev Next